SCHEMBL14796348

SCHEMBL14796348

COc1ccc2[nH]c(=O)c3c(c2c1)C(=O)c1cc(Br)ccc1-3

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
MAPT P10636 3/20 0.45
RAB9A P51151 2/20 0.45
PKM P14618 1/20 0.45
MCL1 Q07820 1/20 0.45
HKDC1 Q2TB90 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 6/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HSD17B10 Q99714 3/20 0.45
TSHR P16473 2/20 0.45
GFER P55789 1/20 0.45
CCNB2 O95067 3/20 0.44
CDK1 P06493 3/20 0.44
CCNB1 P14635 3/20 0.44
GSK3B P49841 3/20 0.44
CCNB3 Q8WWL7 3/20 0.44
GSK3A P49840 2/20 0.44
CDK5 Q00535 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14796414 0.91 ALDH1A1 (0.51) KDM4EMAPTRAB9APKMMCL1
SCHEMBL14796671 0.85 ALDH1A1 (0.51) KDM4EMAPTRAB9APKMMCL1
SCHEMBL14796427 0.81 KDM4E (0.48) KDM4EMAPTALDH1A1CCNB2CDK1
SCHEMBL14796696 0.81 TOP1 (0.60) KDM4EMAPTRAB9APKMNPSR1
SCHEMBL6203750 0.74 ALDH1A1 (0.50) KDM4EMAPTRAB9APKMMCL1
SCHEMBL6976263 0.73 ALDH1A1 (0.78) KDM4EMAPTRAB9AALDH1A1MEN1
SCHEMBL31188764 0.73 ALDH1A1 (0.78) KDM4EMAPTRAB9AALDH1A1MEN1
Hydrochloric Acid SCHEMBL7234662 0.73 ABCG2 (0.49) KDM4EMAPTRAB9APKMMCL1
SCHEMBL6824577 0.71 ALDH1A1 (0.47) KDM4EMAPTRAB9AALDH1A1MEN1
SCHEMBL7669097 0.70 ABCG2 (0.68) KDM4EMAPTRAB9APKMMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181193-B2 Indenoquinolone compound, preparation method and use thereof SECOND MILITARY MEDICAL UNIVERSITY, PLA (CN) 2015-11-10 US disclosed
US-20130102598-A1 INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF SECOND MILITARY MEDICAL UNIVERSITY, PLA (CN) 2013-04-25 US disclosed
EP-2573072-A1 INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF The Second Military Medical University, PLA (CN) 2013-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102598-A1 INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF TOP1, TOP2A, TOP2B KDM4E 2199/4885MAPT 3771/4885RAB9A 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.